1. Home
  2. NVS

as 01-10-2025 4:00pm EST

$
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
.
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
-
$
0
1
2
3
4
5
6
7
8
9
.
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
-
0
1
2
3
4
5
6
7
8
9
.
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.

;SMA (50)$102.30EMA (200)$105.65O: $99.47 H: $99.72 L: $99.03 C: $99.09 −0.38 (−0.38%)Elder Ray 1.56, 0.87
Founded: 1895 Country:
Switzerland
Switzerland
Employees: N/A City: N/A
Market Cap: 230.5B IPO Year: 1991
Target Price: $121.25 AVG Volume (30 days): 1.1M
Analyst Decision: Hold Number of Analysts: 6
Dividend Yield:
3.81%
Dividend Payout Frequency: Annual
EPS: 8.58 EPS Growth: 130.53
52 Week Low/High: $92.35 - $120.92 Next Earning Date: 01-31-2025
Revenue: $49,940,000,000 Revenue Growth: 8.92%
Revenue Growth (this year): 10.04% Revenue Growth (next year): 4.55%

NVS Daily Stock ML Predictions

SELLHOLDBUYas of 12 hours ago

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use